. Our Business Overview Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatins strategy is to develop products and then form marketing collaborations with industry leaders to maximize product commercial potential. The MCR ...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-09-28 | 2026-06-30 | 0001493152-26-044572 | EDGAR | 66K words |
| 2025-09-23 | 2025-06-30 | 0001654954-25-011030 | EDGAR | 70K words |
| 2024-09-30 | 2024-06-30 | 0001654954-24-012498 | EDGAR | 69K words |
| 2023-09-28 | 2023-06-30 | 0001654954-23-012335 | EDGAR | 69K words |
| 2022-09-22 | 2022-06-30 | 0001654954-22-012862 | EDGAR | 73K words |
| 2021-09-28 | 2021-06-30 | 0001654954-21-010495 | EDGAR | 64K words |
| 2020-09-25 | 2020-06-30 | 0001654954-20-010471 | EDGAR | 70K words |
| 2019-09-12 | 2019-06-30 | 0001654954-19-010679 | EDGAR | 67K words |
| 2018-09-13 | 2018-06-30 | 0001654954-18-010150 | EDGAR | 69K words |
| 2017-09-25 | 2017-06-30 | 0001654954-17-008792 | EDGAR | 64K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001493152-26-006969 | EDGAR | 21K words |
| 2025-11-14 | 2025-09-30 | 0001654954-25-013091 | EDGAR | 19K words |
| 2025-05-14 | 2025-03-31 | 0001654954-25-005610 | EDGAR | 21K words |
| 2025-02-13 | 2024-12-31 | 0001654954-25-001431 | EDGAR | 19K words |
| 2024-11-14 | 2024-09-30 | 0001654954-24-014335 | EDGAR | 18K words |
| 2024-05-15 | 2024-03-31 | 0001654954-24-006292 | EDGAR | 39K words |
| 2024-02-14 | 2023-12-31 | 0001654954-24-001789 | EDGAR | 38K words |
| 2023-11-14 | 2023-09-30 | 0001654954-23-014251 | EDGAR | 18K words |
| 2023-05-15 | 2023-03-31 | 0001654954-23-006575 | EDGAR | 21K words |
| 2023-02-14 | 2022-12-31 | 0001654954-23-001726 | EDGAR | 22K words |
| 2022-11-14 | 2022-09-30 | 0001654954-22-015282 | EDGAR | 19K words |
| 2022-05-16 | 2022-03-31 | 0001654954-22-006963 | EDGAR | 20K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-03 | 0001493152-26-035722 | EDGAR | 1K words |
| 2025-11-12 | 0001654954-25-012928 | EDGAR | 1K words |
| 2025-11-06 | 0001654954-25-012641 | EDGAR | 1K words |
| 2025-09-22 | 0001654954-25-010973 | EDGAR | 1K words |
| 2025-09-10 | 0001654954-25-010576 | EDGAR | 1K words |
| 2025-08-18 | 0001654954-25-009743 | EDGAR | 1K words |
| 2025-08-08 | 0001654954-25-009290 | EDGAR | 1K words |
| 2025-07-29 | 0001654954-25-008579 | EDGAR | 2K words |
| 2025-07-09 | 0001654954-25-007872 | EDGAR | 1K words |
| 2025-06-13 | 0001654954-25-006936 | EDGAR | 10K words |
395 total filings indexed. 363 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000911216 |
| Ticker | PTNT |
| Exchange | — |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NJ |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PTNT (~200 tokens, structured JSON with cryptographic provenance)